As treatment options for erectile dysfunction (ED) continue to expand, and with more attractive alternatives such as effective systemic treatment becoming available, the number of men presenting for treatment of ED is increasing exponentially. Since a subset of these men continue to require surgical therapy, there is a potential for the number of operations for the treatment of ED and related disorders to actually increase. Areas in the surgical treatment of ED where improvements are needed are identi®ed, including: measures to prevent penile prosthesis infections, better penile implants, improved penile augmentation procedures, better surgical procedures for the treatment of Peyronie's disease, improved penile revascularization procedures, and new motor and sensory penile nerve grafting procedures.
Introduction
Urology's main entry into the clinical area of erectile dysfunction (ED) was with the introduction of the in¯atable penile prosthesis in the early 1970s. 1 In the early years following the introduction of this device, treatment was for the most part limited to penile prosthesis implantation for organic ED and sex therapy for psychogenic ED. Since then, a variety of treatment options for ED have been developed including penile vascular surgery, penile injection therapy, vacuum erection device therapy, intraurethral pharmacotherapy, and systemic therapy. While the proportion of men newly diagnosed with ED who undergo surgical treatment has declined, the number of men presenting with ED continues to increase out of proportion to this decline; and the actual number of men who receive surgical treatment of various types in the future is likely to increase. In addition, a longitudinal aspect has been introduced in management of ED. The advent of effective systemic agents such as sildena®l citrate has resulted in large numbers of men with mild to moderate ED presenting for treatment with this agent and other systemic agents soon to be introduced. Many of these men are being effectively treated with this oral drug, but it is likely that, as their ED advances, they may eventually require penile prosthesis implantation or other surgical intervention in order to remain sexually active.
While a great deal of progress has been made in the surgical treatment of ED, there is still room for improvement. In this review we identify some areas where progress is most needed, and we anticipate ways in which this progress might be achieved.
Penile prosthesis implantation
Most would agree that infection is the bane of prosthetic surgery. Jarow 2 reported infection rates of 1.8% in 114 ®rst-time implant recipients, 13.3% in 30 implant revisions, and 21.7% in 23 implants associated with penile reconstruction procedures. Future advances in penile prosthetic surgery will probably include procedural or device modi®cations which will lower these rates.
Penile prosthesis infections are most commonly caused by Gram-negative bacilli and the Grampositive cocci Staphylococcus aureus and Staph. epidermidis. 3, 4 More than 50% of these infections have been attributed to Staph. epidermidis although it has been suggested that this organism in some cases may be a contaminant. 5 Dr F Brantley Scott taught that silicone has a positive charge and that this prosthetic material attracts air borne particles including skin cells shed by operating room personnel. This, he believed, was the probable source of Staph. epidermidis periprosthetic infections. He introduced the Surgical Isolation Bubble System (SIBS) in the 1980s in an attempt to reduce infections, 6 but it was later abandoned without undergoing controlled clinical trials. The SIBS or a similar system may still be capable of reducing this type of infection, and may be worthy of further clinical study. Another possible means of reducing prosthesis related infection includes the use of prostheses impregnated or coated with antibiotics. 7 The ideal penile prosthesis would include, among other attributes, that of being a`one-piece' prosthesis con®ned entirely to the corpora. Semirigid rod prostheses are con®ned to the corpora but are constantly rigid and feel solid when palpated. One-piece hydraulic devices, eg the Surgitek FlexiFlate, 8 the AMS Hydro¯ex 9 and the AMS Dynaex, 10 were developed to ful®ll the need for better one-piece devices but they proved less than fully satisfactory and are no longer available in the United States. Advances in prosthetic design and materials should allow the eventual development of a onepiece prosthesis which is soft when palpated, hangs dependently and is non-rigid when inactivated, and projects from the body and is rigid after activation.
Penile enlargement surgery
There remains considerable controversy surrounding the issue of penile augmentation surgery for men with normal penises. However, if a safe and effective means of augmentation were available, they would certainly bene®t men with penis size considered to be signi®cantly below the mean. Indeed, reasonable guidelines (`4 cm¯accid length or`7.5 cm stretched or erect length) have been suggested for offering penile augmentation to men with small but otherwise normal phalluses. 11 While progress towards penile augmentation is being made, 12 current techniques frequently lead to deformities requiring corrective surgery. 13, 14 Clearly there remains room for progress in this area.
Another related issue is restoring phallus length to men with corporeal ®brosis occurring after removal of an infected penile prosthesis, after prolonged veno-occlusive priapism, or as a result of Peyronie's disease. Knoll et al described placement of a penile prosthesis,¯ap advancement, and prepubic tissue debulking to treat shortened penises following removal of an infected penile prosthesis. 15 Santucci and Berger described multiple`®nger trap' incisions in the tunica albuginea to restore penile length after partial penectomy. 16 Lue and associates described circular venous grafting together with daily penile stretching using a vacuum erection device to restore penile length after Peyronie's disease. 17 None of these techniques have gained widespread use, but they are worthy of further re®nement, and other related techniques are sorely in need of development.
Peyronie's disease surgery
In surgery for Peyronie's disease the plaque is often excised or incised with a scalpel. To reduce the incidence of post-operative ED, Lue and associates suggested thinning of the plaque with a carbon dioxide laser. 18 This technique has not yet gained widespread acceptance but future advances may include the use of laser or other devices to modify or destroy rather than physically excise the plaque.
Both synthetic and a variety of tissue grafts have been used in Peyronie's disease surgery; however, the ideal graft material has yet to be found. Graft harvesting lengthens the operating time, creates a donor site scar, and is potentially associated with hematoma, infection, and other donor site morbidity. A graft which is available in a package would obviate harvesting a tissue graft from the patient. Packaged material such as Dacron or GoreTex is available, and while they have been successfully used to cover penile prostheses, their use in nonprosthetic cases should be avoided because they are inelastic. Processed human cadaveric allograft skin has been used for penile reconstructive procedures, 19 biodegradable acetic acid and acetic anhydride treated pericardium has been used for experimental bladder augmentation, 20 and chemically processed and gamma irradiated cadaveric pericardium has been used in Peyronie's disease. 21 It remains to be seen, however, whether their use as tunica albuginea substitutes may prove less than satisfactory because of resorbtion and replacement by ®brous tissue. The ideal synthetic graft, which has yet to be developed, would have tensile and stretching characteristics similar to that of healthy tunica albuginea. Currently, grafts are sutured into place. Future advances will probably also include tissue welding techniques to replace time-consuming suturing. 22 
Penile revascularization
Revascularization for vasculogenic ED has had reasonable success in the small numbers of young men with ED following pelvic or perineal trauma. 23 Success rates for arterial revascularization in older men with atherosclerosis are notably less probable, in part, because of associated cavernosal smooth muscle disease. 24 Advances in medical treatment for cavernosal smooth muscle disease such as gene therapy, may extend the ability of urologists to provide successful penile arterial revascularization for many of the older men who are suffering from vasculogenic ED. Furthermore, advances in microsurgical tissue welding techniques may result in sutureless vascular anastomoses in these small vessels.
Penile reinnervation
Spinal cord injury, pelvic fracture, perineal trauma, radical prostatectomy, radical cystectomy, and proctectomy are all frequently associated with neurogenic ED. Kim and associates have demonstrated the feasibility of sural nerve interposition for treatment of ED following radical prostatectomy. 25 This technique may be extended to treat neurogenic ED of other causes. Similar techniques may prove useful in treating penile anesthesia or dysesthesia which follow iatrogenic or other types of injury to the sensory nerves of the penis.
Conclusions
Treatment options for ED continue to expand, and many more men with ED are presenting for treatment. Surgical intervention will still be necessary for a subset of these individuals with the number of operations for ED potentially increasing in the future. Needed advances in the surgical treatment for ED include prosthesis infection deterrents, better penile prosthetic devices, improved penile enlargement procedures, synthetic tunica albuginea, microsurgical vascular anastomosis tissue welds, and improved motor and sensory penile nerve grafting.
